Treace Medical Concepts Inc • TMCI

Capital at risk.

About Treace Medical Concepts Inc
Ticker
info
TMCI
Trading on
info
NASDAQ
ISIN
info
US89455T1097
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
John T. Treace
Headquarters
info
100 Palmetto Park Place, Ponte Vedra, FL, United States, 32081
Employees
info
477
Website
info
treace.com
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Metrics
BasicAdvanced
Market cap
info
$395M
P/E ratio
info
-
EPS
info
-$0.79
Dividend Yield
info
0.00%
Beta
info
0.69
Forward P/E ratio
info
0
EBIDTA
info
$-39.4M
Ex dividend date
info
-
Price & volume
Market cap
info
$395M
Average daily volume
info
0.5M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
1.85
Price to book
info
4.05
Earnings
EPS
info
-$0.79
EPS estimate (current quarter)
info
-$0.29
EPS estimate (next quarter)
info
-$0.24
EBITDA
info
$-39.4M
Revenues (TTM)
info
$214M
Revenues per share (TTM)
info
$3.42
Technicals
Beta
info
0.69
52-week High
info
$10.79
52-week Low
info
$5.16
50-day moving average
info
$6.76
200-day moving average
info
$7.17
Short ratio
info
12.38
Short %
info
7.38%
Management effectiveness
ROE (TTM)
info
-46.89%
ROA (TTM)
info
-13.83%
Profit margin
info
-23.01%
Gross profit margin
info
$171M
Operating margin
info
-35.82%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
6.60%
Share stats
Outstanding Shares
info
63.2M
Float
info
47.2M
Insiders %
info
25.61%
Institutions %
info
60.63%
Analyst Insights & forecasts
info

29% Buy

71% Hold

0% Sell

Based on information from 7 analysts.

Average price target

info
$8.42
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.25
-$0.27
7.41%
Q3 • 24Beat
-$0.00
-$0.04
96.25%
Q4 • 24Beat
-$0.25
-$0.30
18.33%
Q1 • 25Beat
-$0.28
-$0.29
3.45%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$52.6M
$-15.9M
-30.29%
Q1 • 25
$47.4M
$-17.4M
-36.71%
Q2 • 25
-9.86%
9.27%
21.22%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$206M
$101M
48.83%
Q1 • 25
$206M
$109M
52.72%
Q2 • 25
0.29%
8.28%
7.97%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$4.2M
$-1.9M
$-0.3M
$0.7M
Q1 • 25
$-3.1M
$-3.3M
$1M
$-7.8M
Q2 • 25
-172.65%
71.96%
-450.00%
-1,293.44%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Treace Medical Concepts Inc share?
Collapse

Treace Medical Concepts Inc shares are currently traded for undefined per share.

How many shares does Treace Medical Concepts Inc have?
Collapse

Treace Medical Concepts Inc currently has 63.2M shares.

Does Treace Medical Concepts Inc pay dividends?
Collapse

No, Treace Medical Concepts Inc doesn't pay dividends.

What is Treace Medical Concepts Inc 52 week high?
Collapse

Treace Medical Concepts Inc 52 week high is $10.79.

What is Treace Medical Concepts Inc 52 week low?
Collapse

Treace Medical Concepts Inc 52 week low is $5.16.

What is the 200-day moving average of Treace Medical Concepts Inc?
Collapse

Treace Medical Concepts Inc 200-day moving average is $7.17.

Who is Treace Medical Concepts Inc CEO?
Collapse

The CEO of Treace Medical Concepts Inc is John T. Treace.

How many employees Treace Medical Concepts Inc has?
Collapse

Treace Medical Concepts Inc has 477 employees.

What is the market cap of Treace Medical Concepts Inc?
Collapse

The market cap of Treace Medical Concepts Inc is $395M.

What is the P/E of Treace Medical Concepts Inc?
Collapse

The current P/E of Treace Medical Concepts Inc is null.

What is the EPS of Treace Medical Concepts Inc?
Collapse

The EPS of Treace Medical Concepts Inc is -$0.79.

What is the PEG Ratio of Treace Medical Concepts Inc?
Collapse

The PEG Ratio of Treace Medical Concepts Inc is null.

What do analysts say about Treace Medical Concepts Inc?
Collapse

According to the analysts Treace Medical Concepts Inc is considered a hold.